# Ventas, Inc. – Consensus ‘buy’ rating and 14.2% Upside Potential

- Link: https://www.directorstalkinterviews.com/ventas-inc.consensus-buy-rating-and-14.2-upside-potential/4121132408
- Published: 2023-11-09T12:25:05+00:00
- Author: Charlotte Edwards

**Ventas, Inc.** which can be found using ticker (VTR) now have 17 confirmed analysts
covering the stock with the consensus suggesting a rating of ‘buy’. The range between
the high target price and low target price is between $58.00 and $44.00 calculating
the mean target price we have $50.00. Given that the stocks previous close was at
$43.78 and the analysts are correct then we can expect a percentage increase in 
value of 14.2%. There is a 50 day moving average of $42.59 while the 200 day moving
average is $45.47. The company has a market capitalization of 17.71B. The current
share price for the company is: $44.02 USD

 The potential market cap would be $20,229,342,202 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of 2201, revenue per share of $10.87
and a 1.58% return on assets.

Ventas, Inc. is a real estate investment trust (REIT). The Company is engaged in
operating at the intersection of healthcare and real estate. It has a portfolio 
of senior housing communities, medical office buildings (MOBs), life science, research
and innovation centers, hospitals and other healthcare facilities. The Company’s
segments include Triple-Net Leased Properties, Senior Housing Operating Portfolio(
SHOP), and Office Operations. Triple-Net Leased Properties is engaged in investing
in and owning senior housing and healthcare properties throughout the United States
and the United Kingdom and leasing those properties to healthcare operating companies
under triple-net or absolute-net leases. The Senior Housing Operating Portfolio (
SHOP) segment invests in senior housing communities throughout the United States
and Canada. The Office Operations segment acquires, owns, develops, leases and manages
MOBs and life science, research and innovation centers throughout the United States.

Share on: